179 related articles for article (PubMed ID: 22744182)
1. Enhanced plasma factor VIII activity in mice via cysteine mutation using dual vectors.
Zhu F; Liu Z; Miao J; Qu H; Chi X
Sci China Life Sci; 2012 Jun; 55(6):521-6. PubMed ID: 22744182
[TBL] [Abstract][Full Text] [Related]
2. [Trans-splicing of Cys mutated coagulation factor VIII].
Zhu FX; Liu ZL; Miao J; Qu HG; Chi XY
Yao Xue Xue Bao; 2012 Jun; 47(6):734-8. PubMed ID: 22919720
[TBL] [Abstract][Full Text] [Related]
3. Inter-chain disulfide bond improved protein trans-splicing increases plasma coagulation activity in C57BL/6 mice following portal vein FVIII gene delivery by dual vectors.
Zhu F; Liu Z; Wang X; Miao J; Qu H; Chi X
Sci China Life Sci; 2013 Mar; 56(3):262-7. PubMed ID: 23526393
[TBL] [Abstract][Full Text] [Related]
4. [Leucine zippers improves protein splicing-mediated coagulation factor VIII gene delivery by dual-vector system].
Zhu FX; Yang SD; Liu ZL; Miao J; Qu HG; Chi XY
Yao Xue Xue Bao; 2012 Jan; 47(1):39-44. PubMed ID: 22493803
[TBL] [Abstract][Full Text] [Related]
5. Protein trans-splicing based dual-vector delivery of the coagulation factor VIII gene.
Zhu F; Liu Z; Chi X; Qu H
Sci China Life Sci; 2010 Jun; 53(6):683-9. PubMed ID: 20602271
[TBL] [Abstract][Full Text] [Related]
6. Phenotype correction of hemophilia A mice with adeno-associated virus vectors carrying the B domain-deleted canine factor VIII gene.
Ishiwata A; Mimuro J; Kashiwakura Y; Niimura M; Takano K; Ohmori T; Madoiwa S; Mizukami H; Okada T; Naka H; Yoshioka A; Ozawa K; Sakata Y
Thromb Res; 2006; 118(5):627-35. PubMed ID: 16371232
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
[TBL] [Abstract][Full Text] [Related]
8. Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy.
Ogata K; Mimuro J; Kikuchi J; Tabata T; Ueda Y; Naito M; Madoiwa S; Takano K; Hasegawa M; Ozawa K; Sakata Y
Gene Ther; 2004 Feb; 11(3):253-9. PubMed ID: 14737084
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an adenoviral vector encoding full-length human factor VIII in hemophiliac mice.
Connelly S; Andrews JL; Gallo-Penn AM; Tagliavacca L; Kaufman RJ; Kaleko M
Thromb Haemost; 1999 Feb; 81(2):234-9. PubMed ID: 10063998
[TBL] [Abstract][Full Text] [Related]
10. [Ssp DnaB intein-mediated ligation of heavy and light chains of coagulation factor VIII in Escherichia coli].
Zhu F; Liu Z; Qu H; Xin X; Dong H; Liu X
Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1101-6. PubMed ID: 19835155
[TBL] [Abstract][Full Text] [Related]
11. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice.
Connelly S; Smith TA; Dhir G; Gardner JM; Mehaffey MG; Zaret KS; McClelland A; Kaleko M
Hum Gene Ther; 1995 Feb; 6(2):185-93. PubMed ID: 7537539
[TBL] [Abstract][Full Text] [Related]
12. Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice.
Bunting S; Zhang L; Xie L; Bullens S; Mahimkar R; Fong S; Sandza K; Harmon D; Yates B; Handyside B; Sihn CR; Galicia N; Tsuruda L; O'Neill CA; Bagri A; Colosi P; Long S; Vehar G; Carter B
Mol Ther; 2018 Feb; 26(2):496-509. PubMed ID: 29292164
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
[TBL] [Abstract][Full Text] [Related]
14. [vWF improves secretion and activity of intein spliced BDD-FVIII].
Zhu FX; Yang SD; Liu ZL; Miao J; Qu HG; Chi XY
Yao Xue Xue Bao; 2010 May; 45(5):595-600. PubMed ID: 20931761
[TBL] [Abstract][Full Text] [Related]
15. [Glycosylation and L303e/F309S mutations improve intein-mediated splicing of the split coagulation factor VIII].
Zhu FX; Liu ZL; Miao J; Qu HG; Chi XY
Yao Xue Xue Bao; 2010 Nov; 45(11):1361-6. PubMed ID: 21361035
[TBL] [Abstract][Full Text] [Related]
16. [Enhancing effect of porcine coagulation factor VIII A1 and A3 domains on secretion of post-translationally spliced human/porcine hybrid coagulation factor VIII].
Zhu FX; Liu ZL; Qu HG; Chi XY
Sheng Li Xue Bao; 2010 Aug; 62(4):373-81. PubMed ID: 20717639
[TBL] [Abstract][Full Text] [Related]
17. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
Liu L; Mah C; Fletcher BS
Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640
[TBL] [Abstract][Full Text] [Related]
18. [Intein-mediated F309SfVIII ligation with enhanced secretion of its heavy chain.].
Zhu FX; Liu ZL; Qu HG; Chi XY
Sheng Li Xue Bao; 2009 Dec; 61(6):526-32. PubMed ID: 20029685
[TBL] [Abstract][Full Text] [Related]
19. In vivo dose threshold effect of adenovirus-mediated factor VIII gene therapy in hemophiliac mice.
Bristol JA; Shirley P; Idamakanti N; Kaleko M; Connelly S
Mol Ther; 2000 Sep; 2(3):223-32. PubMed ID: 10985953
[TBL] [Abstract][Full Text] [Related]
20. Partial correction of murine hemophilia A with neo-antigenic murine factor VIII.
Sarkar R; Gao GP; Chirmule N; Tazelaar J; Kazazian HH
Hum Gene Ther; 2000 Apr; 11(6):881-94. PubMed ID: 10779165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
